by admin | Jan 13, 2026 | News & Opinions
By Frank Vinluan – MedCity News – A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. Omeros’s complement system drug Yartemlea is now...
by admin | Jan 12, 2026 | News & Opinions
By Matt Hoffman – CGTlive – As 2025 comes to a close, CGTLive has looked back on some of the most-read and most impactful FDA regulatory decisions and news in the cell and gene therapy space. These approvals and regulatory actions marked major progress for...
by admin | Jan 9, 2026 | News & Opinions
By Genetic Engineering adn Biotechnology News – Cancer immunotherapy transforms a patient’s immune cells into a “search‑and‑destroy” force against tumors. But many cancers learn to camouflage themselves from dendritic cells—the immune system’s scouts—making them...
by admin | Jan 8, 2026 | News & Opinions
by Tel-Aviv University – MedXpress – A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells...
by admin | Jan 7, 2026 | News & Opinions
By William A. Haseltine, – Forbes – Treating brain diseases is extraordinarily challenging, because drugs often work poorly and implants require risky surgery that can jeopardize critical brain functions. A group at MIT has sought a different approach,...
by admin | Jan 6, 2026 | News & Opinions
By Anne Trafton, Massachusetts Institute of Technology – ScitTechDaily – As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development. As people get older,...
